3
Announcements
Trials
Browse
Landscape
Sponsor
Cancer Type
Genitourinary
1
Endocrine
1
Interventions
lutetium Lu 177 dotatate
8
Specimen Handling
5
Magnetic Resonance Spectroscopy
5
pembrolizumab
3
Everolimus
3
cabozantinib
2
X-Rays
2
repotrectinib
1
peposertib
1
pazopanib
1
olaparib
1
lenvatinib
1
fludarabine
1
entrectinib
1
belinostat
1
aldesleukin
1
Watchful Waiting
1
Tomography, X-Ray Computed
1
Tomography, Emission-Computed, Single-Photon
1
Sunitinib
1
Single Photon Emission Computed Tomography Computed Tomography
1
Salts
1
Positron Emission Tomography Computed Tomography
1
Photons
1
Phantoms, Imaging
1
PT-100 dipeptide
1
Octreotide
1
Nivolumab
1
Lutetium-177
1
Lutetium
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
copper dotatate CU-64
×
NET
×
30 days
×
Clear all
No trials found.